during the quickly evolving area of oncology analysis, precise and economical mutation screening is vital for establishing focused therapies. The KRAS solutions Platform plays a pivotal job On this landscape by featuring in depth answers for KRAS mutation profiling and analysis. KRAS mutations, found in about ninety five% of RAS-associated oncogeni